Close Menu

At MIT's Tech Review, Emily Singer discusses new genetic tests launched by Decode this week. One looks for variations linked to various cardiovascular diseases and the other for variations associated with cancer risk and they are priced at $195 and $225. However, the clinical utility of tests that include multiple genetic risk factors hasn't yet been worked out. "We don't yet know how to combine such data in an accurate way," UNC-Chapel Hill's James Evans says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.